Summary: Luxor Scientific has entered a strategic partnership with Capstone Health Alliance to provide advanced diagnostic testing solutions to Capstone’s extensive network of healthcare providers.

Takeaways:

  1. Strategic Partnership: Luxor Scientific’s collaboration with Capstone Health Alliance aims to enhance healthcare outcomes through innovative diagnostic solutions.
  2. Advanced Testing Solutions: Luxor offers cutting-edge tests, including the unique OWLiver serum test and in-office Epidermal Nerve Fiber Density testing, among others.
  3. Improved Patient Care: The partnership is focused on delivering faster, accurate diagnostic results to help physicians make better treatment decisions, thereby improving patient care.

Luxor Scientific, a provider of clinical diagnostics, has entered into a strategic partnership with Capstone Health Alliance, a regional group purchasing organization (GPO) in the US health care industry. This collaboration will grant Capstone’s membership of health systems, independent hospitals, and physician offices across the country access to cutting-edge diagnostic testing and expedited results.

Strategic Partnership Provides Testing Solutions

A full-service, privately held medical and research laboratory, Luxor Scientific offers advanced testing solutions that often lead the industry in response to health care concerns nationwide. Driven by its team of scientists and operational leaders, Luxor has developed proprietary technology to increase speed and provide accurate results.

“We are thrilled to collaborate with Capstone Health Alliance to provide our diagnostic tests to its extensive network. Our aim is to improve patient care by delivering innovative diagnostic solutions with industry-leading turnaround times that will aid physicians in selecting appropriate treatment plans for their patients to live healthier and happier lives,” says Marion Snyder, Ph.D., chief science officer of Luxor Scientific. ”The announcement of this collaboration marks the start of a partnership aimed at improving healthcare outcomes for more patients. Luxor Scientific’s extensive array of laboratory services is now accessible to members of Capstone Health Alliance.”

Examples of the cutting-edge tests that Luxor Scientific provides include: 

  • OWLiver, the only serum test based off the MASEF Score able to identify all damaging phases of MASLD, formally known as NAFLD.
  • Epidermal Nerve Fiber Density (ENFD) Testing, a highly sensitive and specific test done in-office for documenting small fiber peripheral neuropathy.
  • Clinical Medication Monitoring & Toxicology, extensive testing of urine and oral fluid samples for over 100 drugs including emerging novel illicits xylazine, pentylone, nitazenes, bromazolam, and tianeptine.
  • CannabisConfirm, a custom solution for identifying if patients have taken Delta-8- or Delta-9-THC amidst the significant increase in usage of CBD products.
  • Molecular Pathogen, both traditional microbiology and rapid PCR testing for infectious diseases.

“We are excited to join forces with Luxor Scientific to offer Capstone Health Alliance Members access to critical diagnostic tests and the information they provide to deliver optimal, timely patient care,” says Fred J. Pane, R. Ph., FASHP, FABC, vice president of Pharmacy Services at Capstone Health Alliance. “Most importantly, Luxor’s tests will equip our Members with the ability to enhance treatment efficacy.”